Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ...

Ozempic, or semaglutide, is a new obesity drug, delivered in the form of a hormone injection. Metformin is a pill that was first developed for type 2 diabetes. Both drugs can help people lose weight, ...

Exercise has many healthy benefits, but it only plays a small role in weight loss. Working out makes up about 5% of the energy we burn in a day, according to research. Keeping our bodies running uses ...

The biggest fitness trend of 2025 was simple — people chose routines that were easy, enjoyable, and stress-free. Strict diets and exhausting workout regimes took a backseat, while sustainable and ...

Turn weight loss into a simple data project using TDEE and a Google Sheets calorie spreadsheet, so you can stop guessing, set a clear budget, and see real trends in your progress.

Novo Nordisk stock faces bearish technicals, but analysts forecast nearly 46% upside. Novo inks $285 million Ascendis deal, advancing GLP-1 drugs for diabetes and heart health. Ready to turn the ...